Press Room
Lpath to Begin Trading on NASDAQ Capital Market
10/29/2012
Lpath, Inc. (OTCQB: LPTND), the industry leader in bioactive lipid-targeted therapeutics, has received confirmation that its application to list the company's common stock on the NASDAQ Capital Market has been approved by the NASDAQ Stock Market, a unit of the NASDAQ OMX Group.
Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines
10/28/2012
Multitargeted tyrosine kinase inhibitors (TKIs) (such as Sunitinib and Sorafenib) and mTOR inhibitors (such as Temsirolimus) are effective in treating metastatic clear-cell renal cell carcinoma (CCRCC), by acting on different pathways in both tumour and endothelial cells. A study of their combined effect could be of major interest.
Germline SDHB Mutations and Familial Renal Cell Carcinoma
10/25/2012
These findings 1) demonstrate that patients with suspected inherited RCC should be examined for germline SDHB mutations, 2) suggest that all identified SDHB mutation carriers should be offered surveillance for RCC, and 3) provide a further link between familial RCC and activation of hypoxic-gene response pathways.
Give Kids the World kicks off $100M campaign with new guest villas
10/25/2012
"Princess Alyssa," as she's known by staff and volunteers, first visited the resort when she was 3 years old and had been diagnosed with kidney cancer. After her visit, doctors found that the cancer was in remission.
Promising New Cancer Treatments
10/25/2012
Exelixis has completed the rolling submission of its New Drug Application (NDA) for cabozantinib...
Get on the map at Kidney Cancer Connect
10/23/2012
“Get on the map!” Bill Bro, CEO of Chicago-based Kidney Cancer Association (KCA), encourages families that are dealing with kidney cancer to join the charity’s newest social network, KidneyCancer.ME.
Reversible Posterior Leukoencephalopathy Syndrome Induced by Pazopanib
10/23/2012
The reversible posterior leukoencephalopathy syndrome is a clinical/radiological syndrome characterized by headache, seizures, impaired vision, acute hypertension, and typical magnetic resonance imaging findings. There are several reports in the literature that depict its occurrence in cancer patients.
Myths and Facts About Kidney Cancer
10/23/2012
Are the following statements myths or facts about kidney cancer?
Cancer risk increase linked with opioid use
10/23/2012
The study is the first to provide evidence of an association between blood-borne virus infection and cancer risk in people with opioid dependency, finding an increased risk for 11 cancers. Six cancers, including prostate and breast cancer, showed a reduced risk.
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
10/22/2012
mTORC1 is a validated therapeutic target for renal cell carcinoma (RCC)
News Feed| Powered by NeonCRM |